Prakt. lékáren. 2011; 7(6): 262-264

Pharmacotherapy of alcohol dependence

Lukáš Láznička
Lékárna U Divadla, Opava

Alcohol dependence is a progressive chronic disorder. Treating alcoholism involves several stages. The initial stage deals with acute

withdraw or delirium. Later stages attempt to maintain abstinence combine both pharmacotherapy and psychotherapy. In clinical trials

has been shown the effect of disulfiram, acamprosat, naltrexon and serotonergic agents and their combinations.

Keywords: alcohol dependence, disulfiram, naltrexon, acamprosat

Published: December 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Láznička L. Pharmacotherapy of alcohol dependence. Praktické lékárenství. 2011;7(6):262-264.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Sovinová H, Csémy L. The Czech Audit: Internal consistency, latent structure and identification of risky alcohol consumption. Cent Eur J Public Health 2010; 18(3): 127-131. Go to original source... Go to PubMed...
    2. Mayo-Smith MF. Pharmacological Management of Alcohol Withdrawal: A Meta-analysis and Evidence-Based Practice Guideline. JAMA 1997; 278(2): 144-151. dostupný http://med.brown.edu/DPHB/training/psychiatry_general/html/courses/C-L/tx_withdrawal.pdf. Go to original source... Go to PubMed...
    3. Garbutt JC, West SL, Carey TS, Lohr KN, Crews FT. Pharmacological treatment of alcohol dependence: a review of the evidence. JAMA 1999; 281(14): 1318-1325. dostupný z http://jama.ama-assn.org/content/281/14/1318.full.pdf. Go to original source... Go to PubMed...
    4. De Sousa A. An open randomized study of comparing dislufiram and acamprosat in thetreatment of dependence. Alcohol and Alcoholism 2004; 40(6): 545-548. dostupné z http://alcalc.oxfordjournals.org/content/40/6/545.full. Go to original source... Go to PubMed...
    5. Švestka J. Nová psychofarmaka: Acamprosat - anticravingové (antidipsotropní) antialkoholikum. Psychiatrie 1999; 1999(4): 259-263.
    6. Nešpor K, Matanelli O, Randák D, Mráčková E. Sublinguální užití acamprosátu jako krizové intervence ke zvládnutí bažení. Čes a slov Psychiat 2001; 8: 411-413.
    7. Švestka J. Naltrexon v léčbě závislosti na alkoholu. Psychiatrie 2005; 8(2): 109-116.
    8. Krina HP. Pharmacologic Management of Alcohol Dependence. US Pharm 2009; 34(11): 1-4. dostupné z http://www.uspharmacist.com/content/d/feature/c/16522/.
    9. Johnson BA, Rosenthal N, Capece JA, et al. Topiramatefortreatingalcohol dependence: a randomizedcontrolled trial. JAMA 2007; 298: 1641-1651. Go to original source... Go to PubMed...
    10. Anton RF, Myrick H, Wright TM, Latham PK, Baros AM, Waid LR, Randall PK. Gabapentin combined with naltrexonef or thetreatment of alcohol dependence. Am J Psychiatry 2011; 168(7): 709-717. Go to original source... Go to PubMed...
    11. Kampman KM, et al. A double-blind, placebo-controlled pilot trial of quetiapine for thetreatment of Type A and Type B alcoholism. J ClinPsychopharmacol 2007; 27(4): 344-351. Go to original source... Go to PubMed...
    12. Kogoj D, Lesch OM, Blüml V, RieglerA, Vyssoki B, Schlaff G, Walter H. Lesch Alcoholism Typology Medical Treatment and Research. Archives of Psychiatry and Psychotherapy 2010; 4: 37-48.

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.